Merck (MRK) Short-term Investments (2009 - 2026)

Merck (MRK) has 17 years of Short-term Investments data on file, last reported at $375.0 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $375.0 million, down 37.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $375.0 million (down 37.4% YoY), and the FY2024 annual result was $447.0 million, up 77.38% from the prior year.
• Short-term Investments climbed to $375.0 million in Q1 2026 per MRK's latest filing, from $45.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $718.0 million in Q2 2023 and troughed at $40.0 million in Q1 2024.
• A 5-year average of $361.0 million and a median of $375.0 million in 2026 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments plunged 94.12% in 2024, then surged 1397.5% in 2025.
• A 5-year view of Short-term Investments shows it stood at $498.0 million in 2022, then plunged by 49.4% to $252.0 million in 2023, then jumped by 77.38% to $447.0 million in 2024, then sank by 89.93% to $45.0 million in 2025, then soared by 733.33% to $375.0 million in 2026.
• Business Quant data shows MRK's Short-term Investments at $375.0 million in Q1 2026, $45.0 million in Q3 2025, and $615.0 million in Q2 2025.